A histopathological investigation on the effects of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the mandible of rats

Journal of Periodontology

Volumn 71, Issue 5, 2000, Pages 790-796

  Kaynak, Deniz ^a   Meffert, Roland ^b   Günhan, Meral ^a   Günhan, Ömer ^c   Özkaya, Özay ^d  

^a ANKARA UNIVERSITY   (Turkey)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Alveolar bone loss; Bisphosphonates, amino therapeutic use; Bone resorption prevention and control; Osteoclasts; Surgical flaps

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; COLLAGEN FIBER;

ALVEOLAR BONE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; CELL ACTIVITY; CELL INFILTRATION; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; MANDIBLE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PERIOSTEUM GRAFT; PLASTIC SURGERY; RAT;

EID: 0033931788     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2000.71.5.790     Document Type: Article

References (47)

1. Robey PG. Bone remodeling: Formation. In: Brighton CT, Friedlaender G, Lane JM, eds. Bone Formation and Repair. Rosemont, IL: American Academy of Orthopaedic Surgeons; 1994:253-255.
2. Frost MH. The biology of fracture healing: An overview for clinicians. Part I. Clin Orthop 1989;248:283-293.
3. Frost MH. The biology of fracture healing: An overview for clinicians. Part II. Clin Orthop 1989;48:294-309.
4. Yaffe A, Fine N, Binderman I. Regional accelerated phenomenon in the mandible following mucoperiosteal flap surgery. J Periodontol 1994;65:79-83.
5. Bragger U, Pasquali L, Kornman KS. Remodeling of interdental alveolar bone after periodontal flap procedure assessed by means of computer assisted densitometer image analysis (CADIA) for the assessment of alveolar bone density changes in furcations. J Clin Periodontol 1989;16:46-52.
6. Fleish H. Bisphosphonates-history and experimental basis. Bone 1987;8:s23-s28.
7. Fleish H. Bisphosphonates-Pharmacology and use in the treatment of tumour-induced hypercalcemic and metastatic bone disease. Drugs 1991;42:919-944.
8. Fleish H. Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science 1969;165:1262-1264.
9. Fast DK, Felix R, Dowse C, Newman WF, Fleish H. The effects of diphosphonates on the growth and glycolysis of connective tissue cells in culture. Biochem J 1978; 172:97-107.
10. Shinoda H, Adamek G, Felix R, Fleish H, Schenk R, Hagan P. Structure-activity relationships of various bisphosphonates. Calcif Tissue Int 1983;35:87-99.
11. Carono A, Teitelbaum SL, Konsek JD, Schlesinger PH, Blair HC. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest 1990;85:456-461.
12. Felix R, Russell RGG, Fleish H. The effect of several diphosphonates on acid phosphohydrolases and other lysosomal enzymes. Biochem Biophys Acta 1976;429: 429-438.
13. Felix R, Bettex JD, Fleish H. Effect of diphosphonates on the synthesis of prostaglandins in calvaria cells. Calcif Tissue Int 1981;33:549-552.
14. 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res 1973;11:196-214.
15. 2 MDP) and of ethane-1-hydroxy-1, 1-diphosphonate (EHDP) on growth and modeling of the rat tibia. Calcif Tissue Res 1977; 23:207-214.
16. Plasmans CMT, Jap PHK, Kuijpers W, Jloof TJJH, Wigers M. Influence of a diphosphonate on the cellular aspect of young bone tissue. Calcif Tissue Int 1980;32: 247-256.
17. Fleish H. Experimental basis for the use of bisphosphonates in Paget's disease of bone. Clin Orthop Rel Res 1987;217:72-78.
18. Stone MD, Marshall DH, Hosking DJ, Perkins AC, Evans AJ, Wastie ML. Bisphosphonate space measurement in Paget's disease of bone treated with APD. J Bone Miner Res 1992;7:295-301.
19. Gucalp R, Ritch P, Wiernik PH, et al. Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer related hypercalcemia. J Clin Oncol 1992;20:134-142.
20. Fleish H. The possible use of biphosphonates in osteoporosis. In: Deluca HF, Mazess R, eds. Osteoporosis: Physiological Basis, Assessment and Treatment. Amsterdam: Elsevier; 1990:323-329.
21. Yaffe A, Izitkovich M, Earon Y, Alt I, Rilov R, Binderman I. Local delivery of an amino bisphosphonate prevents the resorptive phase of alveolar bone following mucoperiosteal flap surgery in rats. J Periodontol 1997;68:884-889.
22. Boonekamp PM, van der Wee-Pals LJA, van Wijk-van Lennep MML, Thesing CW, Bizvoet OLM. Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. Bone Miner 1986;1:27-39.
23. Flanagan AM, Chambers TJ. Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone. Bone Miner 1989;6:33-43.
24. Carano A, Teitelbaum SL, Konsek JD, Schlesinger PH, Blair HC. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest 1990;85:456-461.
25. Lowik CW, van der Pluijm G, van der Wee-Pals LJ, van Treslong de Groot HB, Bijvoet OL. Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts. J Bone Miner Res 1988;3:185-192.
26. Cecchini MG, Felix R, Fleisch H, Cooper PH. Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages. J Bone Miner Res 1987;2:135-142.
27. Hughes DE, MacDonald BR, Russell RG, McGowen M. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest 1989;83:1930-1935.
28. Papapoulos SE, Hoekmen K, Lowik CW, Vermeij P, Bijvoet OL. Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonate. J Bone Miner Res 1989;4:775-781.
29. Cecchini MG, Fleisch H. Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage. J Bone Miner Res 1990;5:1019-1027
30. Miller SC, Jee WSS. The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat. Anat Rec 1979; 193:439-462.
31. Plasmans CMT, Jap PHK, Kuypers W, Sloof TJJ. Influence of a diphosphonate on the cellular aspect of young bone tissue. Calcif Tissue Int 1980;32:247-256.
32. Sato M, Grasser W. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy. J Bone Miner Res 1990;5:31-40.
33. Pietschmann P, Stohlawetz P, Brosch S, Steiner G, Smolen JS, Peterlik M. The effect of alendronate on cytokine production, adhesion molecule expression, and transendothelial migration of human peripheral blood mononuclear cells. Calcif Tissue Int 1998;63:325-330.
34. Sato M, Grasser W, Enolo N, et al. Bisphosphonate action: Alendronate localization in rat and bone and effects on osteoclast ultrastructure. Osteoporos Int 1993;3:13-16.
35. 3. Endocrinology 1992;131: 1181-1187.
36. McSheehy PMJ, Chambers TJ. Osteoblast like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology 1986;119:1654-1659.
37. Rodan GA, Martin TJ. Role of osteoblasts in hormonal control of bone resorption: A hypothesis. Calcif Tissue Int 1981;33:349-351.
38. Evely RS, Bonomo A, Schneider HG, Moseley JM, Gallagher JA, Martin TJ. Structural requirement for the action of parathyroid hormone-related protein (PTHrp) on bone resorption by isolated osteoclasts. J Bone Miner Res 1991;6:85-93.
39. 3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. J Clin Invest 1987;80:425-429.
40. 2 initially inhibits and then stimulates bone resorption in isolated rabbit osteoclast cultures. Bone Miner 1989;7:255-266.
41. Thomson BM, Saklatvala J, Chambers TJ. Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J Exp Med 1986;164:104-112.
42. Thomson B, Mundy GR, Chambers TJ. Tumor necrosis factors a and β induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 1987;138:775-779.
43. Sahni M, Guenther HL, Fleisch H, Collin P, Martin TJ. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 1993;91:2004-2011.
44. Weinreb M, Quartuccio H, Seedor JG, et al. Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkeys. J Periodont Res 1994;29:35-40.
45. Reddy MS, Weatherford TW, Smith CA, et al. Alendronate treatment of naturally occurring periodontitis in beagle dogs. J Periodontol 1995;66:211-217.
46. Shoji K, Horiuchi H, Shinoda H. Inhibitory effects of a bisphosphonate (risedronate) on experimental periodontitis in rats. J Periodont Res 1995;30:277-284.
47. Grier RL IV, Wise GE. Inhibition of tooth eruption in the rat by a bisphosphonate. J Dent Res 1998;77:8-15.